article
In this interview, Sam Hasson, Senior Director at Rgenta Therapeutics,…
15 June 2023 | By Izzy Wood (Drug Target Review)
In this interview, Sam Hasson, Senior Director at Rgenta Therapeutics, shares his journey in drug discovery, from graduate school to industry, and his current work developing small molecule therapeutics to target RNA processing. He discusses the challenges and opportunities in the field of RNA-centric drug discovery and highlights the potential…